CYCN vs REGN: Which Stock is Better?

Side-by-side comparison of Cyclerion Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

CYCN

Cyclerion Therapeutics Inc

$1.35

REGN

Regeneron Pharmaceuticals Inc

$733.78

Key Metrics Comparison

MetricCYCNREGNWinner
Market Cap$5.14M$77.77BREGN
P/E RatioN/A17.58REGN
EPS (TTM)$N/A$41.75REGN
Revenue Growth3.5%0.0%CYCN
Gross Margin92.6%45.8%CYCN

Analyze CYCN

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CYCN or REGN a better investment?

Comparing CYCN and REGN: Cyclerion Therapeutics Inc has a market cap of $5.14M while Regeneron Pharmaceuticals Inc has $77.77B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CYCN and REGN?

CYCN (Cyclerion Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CYCN or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CYCN or REGN?

CYCN has higher revenue growth at 3.5% vs 0.0% for REGN.

Which company is more profitable: CYCN or REGN?

Cyclerion Therapeutics Inc (CYCN) has higher gross margins at 92.6% compared to 45.8% for REGN.

Which is the larger company: CYCN or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.77B compared to $5.14M for CYCN.

Should I buy CYCN or REGN in 2026?

Both CYCN and REGN have investment merit. CYCN trades at $1.35 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CYCN and REGN stock?

Key differences: Market Cap ($5.14M vs $77.77B), P/E Ratio (N/A vs 17.6x), Revenue Growth (3.5% vs 0.0%), Gross Margin (92.6% vs 45.8%).

Popular Stock Comparisons